NCT01667484View on ClinicalTrials.gov

Adderall XR and Processing Speed in Multiple Sclerosis (MS)

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2015

Conditions
Impaired Processing SpeedCognitive ImpairmentMultiple Sclerosis
Interventions
DRUG

Adderall XR 5mg

DRUG

Adderall XR 10 mg

DRUG

Placebo

Trial Locations (1)

N6G 1W8

London Health Sciences Center and St. Joseph's Heathcare Center (Parkwood), London

Sponsors
All Listed Sponsors
lead

London Health Sciences Centre

OTHER